Richard Armstrong

Director, Registries and Real-World Evidence, NEC Software Solutions

Richard heads NEC’s Registries business.  Having worked extensively in the field of healthcare informatics, he managed delivery of national programmes associated with the collection and reporting of clinical and administrative healthcare data.  His previous roles have included Programme Director of Hospital Episode Statistics (HES) and the national Patient Reported Outcomes (PROMs) service.  He is NEC’s Programme Director for both the National Joint Registry (NJR), and the European Spinal Registry (SpineTango). 

Through his work in registries, Richard has defined and developed information services for surgeons, healthcare managers, industry, regulatory authorities and patients.

Richard represents NEC on the Orthopaedic Data Evaluation Panel (ODEP) and Beyond Compliance, an initiative focused upon supporting the risk-based introduction of new devices to market.

He has particular interest in supporting the development and growth of sustainable, high quality clinical registries servicing multiple stakeholder groups, to enhance assessment of quality, outcome and effectiveness of treatments for patients.

Philip Breedon

Philip Breedon is Professor of Smart Technologies at Nottingham Trent University. Philip is the NTU lead for membership of the UK-Robotics and Autonomous Systems (UKRAS) network and is a member and lead assessor for the UK’s Department of Health National Professor Philip Breedon leads the Medical Engineering Design and Robotics and Intelligent Systems Engineering Research groups at NTU. His PhD is in robotics and AI and he is a Chartered Engineer and Chartered IT professional. He is a deputy chair on the UK’s Department of Health National Institute for Health and Care Research invention for innovation funding panel, a member of the UK-RAS executive committee and the Royal College of Surgeons MSK Robotic and Digital Surgery Subgroup. He is a Royal Academy of Engineering Mentor. Research interests and latest projects centre on surgical and medical product development based on emerging technologies and materials, AI, autonomous and humanoid robotic systems and extended reality technologies.  

Professor Mark Wilkinson

Professor of Orthopaedics, Sheffield Teaching Hospitals, Chair, NJR Research Committee

Professor Wilkinson's principal research interests are in the genetic and metabolic aspects of joint replacement, osteoarthritis, and other associated diseases. Professor Wilkinson is a key clinical collaborator in the Genetics of Osteoarthritis initiative. He and his collaborators have been instrumental in determining our current understanding of the genetic architecture of osteoarthritis. He conducted the first genome-wide scan into hip dysplasia, and into osteolysis and heterotopic ossification after hip replacement, He published the first study in humans to show that bisphosphonates may suppress bone loss after hip replacement and the first clinical trial to show that the human monoclonal antibody denosumab can inhibit osteolysis lesion activity. Other areas of research include exploration of the molecular mechanisms that underpin osteoarthritis development and identifying potential novel pharmacological strategies for its treatment. He has worked on the genetics of osteoarthritis has uncovered novel gene associations with severity and pattern of hip and knee OA, bone remodelling responses to disease, and hip shape. He also studied the systemic health effects of metal ion exposure after hip resurfacing has demonstrated effects on bone cells, cardiovascular, and other systems.

Professor Wilkinson’s principal funding sources are Versus Arthritis, NIHR, Wellcome, MRC, Royal College of Surgeons of England, Cavendish Foundation, John Charnley Trust and industry.

Professor Mike Reed

Consultant Orthopaedic Surgeon and Chair, NJR Surgical Performance Committee, Northumbria Healthcare NHS Foundation Trust,

Professor Mike Reed is a full-time trauma and hip and knee joint replacement surgeon. He trained in the North of England and did fellowships in New Zealand.

He leads Trauma and Orthopaedics at Northumbria Healthcare, working with a team of 31 talented colleagues.

His research focuses on clinical outcomes particularly around short stay surgery as well as infection prevention, diagnosis and management. He has co-developed and commercialised a validated medical device to predict perioperatice risk. Professor Reed is on the steering committee and executive of the National Joint Registry (NJR) and Chaired the Annual Report from 2019-2024. He now leads on Surgical Performance for the NJR, is a trustee for the Orthopaedic Research UK charity and is on the grant awards committee for the National Institute Health and Care Research (NIHR) (i4i PDA). He has led clinical trials for industry and NIHR, and works academically with the University of York.

David Lawson

Policy lead for Medical Technology & Innovation with responsibility for the implementation of the Government's inaugural Medical Technology Strategy published February 2023 and commitments under the 10 Year Health Plan and Life Science Sector Plan published July 2025. Key initiatives include: Design for Life programme, Innovative Devics Access Pathway, Rules Based Pathway, Value Based Procurement guidance, MedTech Compass comparison system, National Product Information Management system, Reform of £1.6bn Part IX Drug Tariff.  Former Chief Procurement Officer at Guy's and St Thomas' NHS Foundation Trust – a position held for 21 years – and double winner of the Supply Chain Excellence Award in 2008 and 2021.

Jing Xie

Senior Vice President, Microport Orthopaedics

Jing Xie is the Senior Vice President, Global Regulatory and Clinical Affairs at MicroPort Orthopedics Inc. She joined MicroPort in September 2021 with over 20 years' experience in leading global teams and developing and executing clinical and regulatory strategies to accelerate market access and market development. Prior to joining MicroPort, Jing held multiple executive level positions, including Sr. Vice President, Global Clinical and Medical Affairs at Smith and Nephew, Vice President, Clinical, Regulatory and Office of Medical Affairs at Medtronic, Vice President, Clinical Affairs, Medical Device Innovation Consortium, Vice President, Global Clinical Affairs at Zimmer Biomet, and Vice President, Global Clinical Research at Biomet. She received her Bachelor of Science in Analytical Chemistry from Xiamen University, her Master of Science in Chemistry and Ph.D. in Materials Science from University of Alabama, and her Master of Science in Computer Science from Purdue University. She also attended the Global Leadership Program at the University of Notre Dame Mendozza College of Business.

Ines Reichert

Consultant Trauma & Orthopaedic Surgeon, King's College Hospital NHS Foundation Trust

Ines Reichert has completed a PhD at Imperial College London prior to her Orthopaedic Training. She is a Consultant Trauma & Orthopaedic Surgeon at King’s College Hospital London a major trauma centre, with subspecialities Upper Limb Hand & Wrist, as well as Diabetic Foot Reconstruction.

She is the R&I Lead for Clinical Research in Trauma & Orthopaedics and leads Undergraduate Teaching in Trauma at her Trust.

Ines Reichert serves nationally on the BOA Research Committee, internationally on the ORS fracture healing section and is President-Elect for the British Orthopaedic Research Society (BORS).

She is specialising in basic science relevant to clinical problems and brings her experience in the conduct of clinical research as well as basic science projects together for improvement of patient care.